Lisata Therapeutics (LSTA) Leases (2016 - 2025)
Lisata Therapeutics' Leases history spans 8 years, with the latest figure at $47000.0 for Q2 2025.
- For Q2 2025, Leases fell 79.11% year-over-year to $47000.0; the TTM value through Jun 2025 reached $47000.0, down 79.11%, while the annual FY2024 figure was $138000.0, 55.19% down from the prior year.
- Leases reached $47000.0 in Q2 2025 per LSTA's latest filing, down from $93000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $425000.0 in Q1 2023 to a low of $47000.0 in Q2 2025.
- Average Leases over 3 years is $242000.0, with a median of $246000.0 recorded in 2024.
- Peak YoY movement for Leases: plummeted 37.18% in 2024, then plummeted 79.11% in 2025.
- A 3-year view of Leases shows it stood at $308000.0 in 2023, then plummeted by 55.19% to $138000.0 in 2024, then tumbled by 65.94% to $47000.0 in 2025.
- Per Business Quant, the three most recent readings for LSTA's Leases are $47000.0 (Q2 2025), $93000.0 (Q1 2025), and $138000.0 (Q4 2024).